Doximity称其临床AI在斯坦福-哈佛独立安全评测中排名领先

Doximity - Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety
Skip to main content
Overview
News
Events
Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Financials
Quarterly Results
SEC Filings
Governance
Governance & ESG Documents
Leadership
Committee Composition
Resources
Investor FAQs
Investor Email Alerts
Investor Contacts
ESG
News Details
View All News
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety
07/15/2026
Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models
SAN FRANCISCO--(BUSINESS WIRE)--
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the most comprehensive independent evaluations of clinical AI safety to date.
The study, conducted by
ARISE
, a clinical AI research team led by physicians from Stanford and Harvard Medical Schools, evaluated how AI models perform when researchers prompted them with simulated patient cases.
Doximity Ask ranked first among all AI systems evaluated on the study's real-world clinical sample, the portion of the benchmark that most closely mirrors how physicians use these tools in practice. Across the broader automated evaluation, purpose-built clinical AI systems outperformed general-purpose frontier models by a wide margin.
Why Doximity Ask Outperformed
Doximity Ask is a HIPAA-compliant AI assistant built specifically for clinical workflows.
Our performance traces directly to our investment in physician authorship at scale. Through our
PeerCheck™
program, more than
11,000 cited physician experts
have evaluated and improved Doximity Ask outputs.
"We have long believed that the path to trustworthy healthcare AI runs through physicians, not around them," said Dr. Louis-Antoine Mullie, Head of Medical AI at Doximity. "Continuous physician review isn't a differentiator. It's a requirement. This result reinforces the importance of combining advanced AI systems with rigorous clinical oversight and independent safety evaluations like NOHARM."
Doximity's Clinical AI Suite, including Ask, has been reviewed, approved, and deployed across more than 150 health systems, including eight of the nation's top 20 hospitals.
The platform includes end-to-end encryption, role-based access controls, audit logging, and session isolation to help healthcare organizations deploy AI while maintaining enterprise-grade security and privacy standards.
To learn more about Doximity Ask, visit
www.doximity.com
.
Read more about the study methodology on the
Doximity blog
Notes to Editors:
For the full study, please click
here
The chart on the left shows how the top U.S. models performed on F1 score, which balances precision and recall, before the cases and answers were made public.
The chart on the right shows automated testing across more than 1,100 scenarios spanning 10 medical specialties. The benchmark was developed by more than 50 researchers with contributions from 29 board-certified physicians.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
Media Contact
Richard George
pr@doximity.com
Investor Contact
Perry Gold
ir@doximity.com
Source: Doximity
Follow us
follow us on facebook
follow us on twitter
follow us on linkedin
follow us on youtube
Links
About Us
Press
Work@
IR Contact
Email Alerts
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
At Doximity, we promise to treat your data with respect and in accordance with the terms of our
Privacy Policy
. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Doximity to send you the requested Investor Email Alert updates.
*
Required
Email Address
Mailing Lists
Events & Presentations
Quarterly Reports
Annual Reports
End of Day Stock Quote
Unsubscribe
Email Alert Sign Up Confirmation
Terms of Use
©
Doximity, Inc. - All rights reserved
Powered By Q4 Inc.
5.183.0.4
(opens in new window)